|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1046977686 |
003 |
OCoLC |
005 |
20231120010308.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
180801s2018 enk ob 000 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d OPELS
|d N$T
|d GZM
|d YDX
|d EBLCP
|d OHS
|d OCLCO
|d CNCGM
|d OCLCO
|d UPM
|d OCLCF
|d OCLCO
|d NLE
|d UKMGB
|d D6H
|d OCLCO
|d OCLCQ
|d OCLCO
|d N$T
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d CASUM
|d OCLCO
|
015 |
|
|
|a GBB8F0625
|2 bnb
|
016 |
7 |
|
|a 019004850
|2 Uk
|
019 |
|
|
|a 1047775463
|a 1048281416
|a 1110183928
|
020 |
|
|
|a 9780128142240
|q (electronic bk.)
|
020 |
|
|
|a 0128142243
|q (electronic bk.)
|
020 |
|
|
|z 9780128142233
|
020 |
|
|
|z 0128142235
|
035 |
|
|
|a (OCoLC)1046977686
|z (OCoLC)1047775463
|z (OCoLC)1048281416
|z (OCoLC)1110183928
|
050 |
|
4 |
|a QP752.S6
|
060 |
|
4 |
|a QU 85
|
072 |
|
7 |
|a SCI
|x 007000
|2 bisacsh
|
082 |
0 |
4 |
|a 572/.57
|2 23
|
245 |
0 |
0 |
|a Sphingolipids in cancer /
|c edited by Charles E. Chalfant, Paul B. Fisher.
|
264 |
|
1 |
|a London :
|b Academic Press,
|c 2018.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in cancer research,
|x 0065-230X ;
|v v. 140
|
588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed August 2, 2018).
|
505 |
0 |
|
|a Front Cover; Advances in Cancer Research; Advances in Cancer Research:Sphingolipids in Cancer; Contents; CONTRIBUTORS; FOREWORD; PREFACE; One -- Mechanisms of Ceramide-Dependent Cancer Cell Death; 1. INTRODUCTION; 2. SPHINGOLIPID METABOLISM AND CANCER; 2.1 Structure and Metabolism of Sphingolipids; 2.2 Enzymes of Ceramide Metabolism and Cancer; 2.2.1 Serine Palmitoyltransferase; 2.2.2 Ceramide Synthases 1-6; 2.2.3 Dihydroceramide Desaturase (DES or DEGS1); 2.2.4 Sphingomyelinases; 2.2.5 Sphingomyelin Synthases and Ceramide Transporter; 2.2.6 Ceramide Kinase; 2.2.7 Glucosylceramide Synthase
|
505 |
8 |
|
|a 2.2.8 Ceramidases3. CERAMIDE IN CANCER CELL DEATH; 3.1 Ceramide and Apoptosis; 3.2 Ceramide and Necroptosis; 3.3 Ceramide and Lethal Autophagy or Mitophagy; 3.4 Ceramide and Endoplasmic Reticulum Stress; 3.5 Ceramide and Cell Cycle Arrest; 4. SPHINGOLIPID METABOLISM AND ANTICANCER THERAPY; 4.1 Ceramide Generation in the Induction of Chemotherapy/Radiation-Mediated Tumor Suppression; 4.2 Ceramide Metabolism in Tumor Immunology and Immunotherapy; 4.2.1 Targeting Sphingolipid Metabolism and Signaling for Cancer Therapy; 5. DISCUSSION; ACKNOWLEDGMENTS; REFERENCES; FURTHER READING
|
505 |
8 |
|
|a Two -- Sphingolipids as Regulators of Autophagy and Endocytic Trafficking1. INTRODUCTION; 2. THE MOLECULAR MACHINERY OF AUTOPHAGY AND REGULATION BY SPHINGOLIPIDS; 2.1 Autophagy Initiation: the Unc-51-Like Kinase Complex; 2.1.1 Sphingolipids in Autophagy Initiation; 2.2 Phagophore Nucleation: the Phosphatidylinositol 3-Kinase Complex; 2.2.1 Sphingolipids in Phagophore Nucleation; 2.3 Phagophore Elongation: LC3 Lipidation; 2.3.1 Sphingolipid-Mediated Regulation of LC3 Lipidation; 2.4 Phagophore Elongation: Membrane Delivery and Autophagic Cargo
|
505 |
8 |
|
|a 2.4.1 Sphingolipid Regulation of Membrane Delivery and Autophagic Cargo2.5 Phagophore Closure; 2.6 Autophagosome-Lysosome Fusion; 2.6.1 Sphingolipids in Autophagosome Maturation; 3. SPHINGOLIPID-MEDIATED AUTOPHAGY IN CANCER: DR. JEKYLL AND MR. HYDE; 3.1 Dr. Jekyll: A Driver of Cancer Cell Survival; 3.2 Mr. Hyde: Inducer of Autophagy-Dependent Cancer Cell Death; 3.2.1 Lethal Mitophagy; 3.2.2 Autophagic Cell Death by Noncanonical Autophagy; 3.2.3 Autophagy-Dependent Lysosomal Membrane Permeabilization; 3.2.4 Autophagy-Dependent Noncanonical Caspase-8 Activation
|
505 |
8 |
|
|a 3.2.5 Autophagy-Dependent Apoptosis via the Calpain-Mediated Cleavage of ATG54. CONCLUSION AND FUTURE DIRECTIONS; REFERENCES; Three -- Role and Function of Sphingomyelin Biosynthesis in the Development of Cancer; 1. STRUCTURE AND INTRACELLULAR DISTRIBUTION OF SPHINGOMYELIN; 2. THE SPHINGOMYELIN SYNTHASE ENZYMES; 3. FUNCTIONS OF THE LIPIDS REGULATED BY THE SPHINGOMYELIN SYNTHASE REACTION; 3.1 Sphingomyelin; 3.1.1 Regulation of Lipid Microdomains in the Outer Leaflet of the Plasma Membrane and Impact on Receptor-Mediated Signaling
|
504 |
|
|
|a Includes bibliographical references.
|
650 |
|
0 |
|a Sphingolipids.
|
650 |
|
2 |
|a Neoplasms
|0 (DNLM)D009369
|
650 |
|
2 |
|a Sphingolipids
|0 (DNLM)D013107
|
650 |
|
6 |
|a Sphingolipides.
|0 (CaQQLa)201-0086675
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Biochemistry.
|2 bisacsh
|
650 |
|
7 |
|a Sphingolipids
|2 fast
|0 (OCoLC)fst01129699
|
655 |
|
4 |
|a Internet Resources.
|
655 |
|
4 |
|a Index not Present.
|
700 |
1 |
|
|a Chalfant, Charles,
|d 1970-
|e editor.
|
700 |
1 |
|
|a Fisher, Paul B.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Sphingolipids in cancer.
|d London : Academic Press, 2018
|z 0128142235
|z 9780128142233
|w (OCoLC)1020030438
|
830 |
|
0 |
|a Advances in cancer research ;
|v v. 140.
|x 0065-230X
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/0065230X/140
|z Texto completo
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128142233
|z Texto completo
|